Loading SUNS…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("SUNS","financials")Full statements spill as a table. For one cell: =jivedata("SUNS","Revenue") or =jivedata("SUNS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
SUNS • CIK 0002012706
| (in thousands, except per share data) | FY 2024 | FY 2025 | TTM |
|---|---|---|---|
| Investment Income, Interest | $10,844.718 | $26,373.418 | $33,499.597 |
| Investment Income, Investment Expense | $216.268 | $4,801.984 | $9,096.031 |
| Revenue from Contract with Customer, Excluding Assessed Tax | $10,628.45 | $21,571.434 | $24,403.566 |
| Financing Receivable, Credit Loss, Expense (Reversal) | $40.18 | $2,029.056 | $2,060.446 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $6,868.421 | $12,142.409 | $13,014.033 |
| Income Tax Expense (Benefit) | $0 | $0 | $0 |
| Labor and Related Expense | $815.301 | $2,454.13 | $4,279.121 |
| General and Administrative Expense | $1,291.021 | $2,896.724 | $3,036.523 |
| Share-based Payment Arrangement, Expense | $338.404 | $1,019.168 | $1,183.927 |
| Professional Fees | $1,275.123 | $1,029.947 | $861.803 |
| Operating Expenses | $3,719.849 | $7,399.969 | $9,361.374 |
| Weighted Average Number of Shares Outstanding, Basic | 6,800,841 | 12,742,894 | 13,840,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 6,835,797 | 12,774,328 | 13,865,022 |
| Dividends | $26.091 | $248.458 | $208.187 |
| Net Income (Loss) Available to Common Stockholders, Basic | $6,842.33 | $11,893.951 | $12,805.846 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 34,956 | 31,434 | 25,022 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 35,447 | 63,489 | 30,214 |
| (in thousands, except per share data) | FY 2024 | FY 2025 | TTM |
|---|---|---|---|
| Liabilities and Equity | $317,535.78 | $310,228.264 | $330,723.592 |
| Financing Receivable, Accrued Interest, before Allowance for Credit Loss | — | $302,674.743 | $296,753.498 |
| Financing Receivable, Allowance for Credit Loss | $21.782 | $1,891.17 | $932.221 |
| Financing Receivable, after Allowance for Credit Loss | $130,711.848 | $300,783.573 | $295,821.277 |
| Cash and Cash Equivalents, at Carrying Value | $184,626.77 | $6,445.328 | $5,593.575 |
| Interest Receivable | $1,138.561 | $2,264.133 | $2,539.215 |
| Prepaid Expense and Other Assets | $1,058.601 | $735.23 | $843.591 |
| Interest Payable | $131.617 | $730.644 | $809.047 |
| Dividends Payable | $2,941.964 | $4,026.296 | $4,055.22 |
| Financing Receivable, Covered, Allowance for Credit Loss | $18.398 | $178.066 | $176.639 |
| Management Fee Payable | $393.063 | $692.716 | $878.995 |
| Accounts Payable and Other Accrued Liabilities | $357.417 | $355.865 | $414.26 |
| Long-term Line of Credit | $0 | — | $50,000 |
| Liabilities | $203,398.033 | $128,265.883 | $148,875.507 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 |
| Common Stock, Value, Issued | $70.047 | $134.21 | $135.174 |
| Additional Paid in Capital | $115,022.034 | $186,745.489 | $187,411.971 |
| Retained Earnings (Accumulated Deficit) | $-954.334 | $-4,917.318 | $-5,699.06 |
| Stockholders' Equity Attributable to Parent | $114,137.747 | $181,962.381 | $181,848.085 |
| Preferred Stock, Shares Authorized | 10,000 | 10,000 | 10,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 50,000,000 | 50,000,000 | 50,000,000 |
| Common Stock, Shares, Issued | 7,004,676 | 13,420,986 | 13,517,402 |
| (in thousands, except per share data) | FY 2024 | FY 2025 | TTM |
|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $6,868.421 | $12,142.409 | $13,014.033 |
| Net Cash Provided by (Used in) Operating Activities | $1,640.535 | $-3,430.578 | $-657.038 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $153,382.148 | $-178,181.442 | $21.954 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $184,626.77 | $6,445.328 | $10,461.387 |
| Financing Receivable, Credit Loss, Expense (Reversal) | $40.18 | $2,029.056 | $2,060.446 |
| Payments to Acquire Loans Held-for-investment | $158,339.598 | $204,576.675 | $192,475.439 |
| Amortization of Debt Issuance Costs | $41.455 | $477.989 | $1,004.418 |
| Proceeds from Principal Repayments on Loans and Leases Held-for-investment | $33,160.685 | $51,516.841 | $136,105.159 |
| Accretion (Amortization) of Discounts and Premiums, Investments | $263.102 | $1,481.495 | $2,530.163 |
| Net Cash Provided by (Used in) Investing Activities | $-125,178.913 | $-153,059.834 | $-57,628.927 |
| Share-based Payment Arrangement, Noncash Expense | $326.904 | $1,019.168 | $1,183.927 |
| Proceeds from Contributed Capital | $80,104.097 | $0 | $0 |
| Proceeds from Issuance of Common Stock | — | $72,588 | $0 |
| Payments of Stock Issuance Costs | — | $1,817.353 | $1,361.464 |
| Payments of Financing Costs | $569.238 | $600.616 | $895.775 |
| Proceeds from Lines of Credit | $248,840 | $214,060 | $223,450 |
| Repayments of Lines of Credit | — | $290,900 | $146,750 |
| Payments of Ordinary Dividends, Common Stock | $1,454.333 | $15,021.061 | $16,134.842 |
| Net Cash Provided by (Used in) Financing Activities | $276,920.526 | $-21,691.03 | $58,307.919 |
| Dividends Payable | $2,941.964 | $4,026.296 | $4,055.745 |
| Liabilities Assumed | — | $2.197 | $-918.641 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $43.197 | $3,724.968 | $7,655.675 |
| Income Taxes Paid, Net | $0 | $0 | $0 |
| Increase (Decrease) in Accrued Interest Receivable, Net | $1,138.561 | $1,125.572 | $429.321 |
| Increase (Decrease) in Prepaid Expense and Other Assets | $530.818 | $-445.998 | $98.457 |
| Increase (Decrease) in Interest Payable, Net | $131.617 | $599.027 | $435.938 |
| Increase (Decrease) in Other Employee-Related Liabilities | $393.063 | $299.653 | $189.855 |
| Increase (Decrease) in Other Operating Liabilities | $715.574 | $-433.278 | $216.109 |
| Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | $347.417 | $-3.749 | $57.414 |